{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T11:52:07Z","timestamp":1783338727622,"version":"3.54.6"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,14]],"date-time":"2023-07-14T00:00:00Z","timestamp":1689292800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicon"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.toxicon.2023.107225","type":"journal-article","created":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T02:08:00Z","timestamp":1689041280000},"page":"107225","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Characterisation of two snake toxin-targeting human monoclonal immunoglobulin G antibodies expressed in tobacco plants"],"prefix":"10.1016","volume":"232","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6678-6999","authenticated-orcid":false,"given":"Catherine M.","family":"Moore","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2158-0601","authenticated-orcid":false,"given":"Anne","family":"Ljungars","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J.","family":"Paul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilla Holst","family":"Dahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirin","family":"Ahmadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Christina","family":"Adams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8042-7108","authenticated-orcid":false,"given":"Lise Marie","family":"Grav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2664-8561","authenticated-orcid":false,"given":"Sanne","family":"Schoffelen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bj\u00f8rn Gunnar","family":"Voldborg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6918-5574","authenticated-orcid":false,"given":"Andreas Hougaard","family":"Laustsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0767-0042","authenticated-orcid":false,"given":"Julian K-C","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.toxicon.2023.107225_bib1","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-67654-7","article-title":"An in vitro methodology for discovering broadly-neutralizing monoclonal antibodies","volume":"10","author":"Ahmadi","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.toxicon.2023.107225_bib2","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/0014-2999(90)94190-9","article-title":"\u03b1-Cobratoxin blocks the nicotinic acetylcholine receptor in rat hippocampal neurons","volume":"191","author":"Alkondon","year":"1990","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.toxicon.2023.107225_bib3","doi-asserted-by":"crossref","first-page":"655","DOI":"10.3389\/fimmu.2020.00655","article-title":"Development of nanobodies against hemorrhagic and myotoxic components of Bothrops atrox snake venom","volume":"11","author":"Bailon Calderon","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.toxicon.2023.107225_bib4","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.tips.2020.05.006","article-title":"Causes and consequences of snake venom variation","volume":"41","author":"Casewell","year":"2020","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.toxicon.2023.107225_bib5","doi-asserted-by":"crossref","first-page":"3280","DOI":"10.1099\/jgv.0.000635","article-title":"Plant-produced anti-dengue virus monoclonal antibodies exhibit reduced antibody-dependent enhancement of infection activity","volume":"97","author":"Dent","year":"2016","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.toxicon.2023.107225_bib6","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.toxicon.2019.02.011","article-title":"Expression of an scFv antibody fragment in Nicotiana benthamiana and in vitro assessment of its neutralizing potential against the snake venom metalloproteinase BaP1 from Bothrops asper","volume":"160","author":"Gomes","year":"2019","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2023.107225_bib7","article-title":"Snakebite envenoming","volume":"3","author":"Guti\u00e9rrez","year":"2017","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.toxicon.2023.107225_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.toxcx.2021.100079","article-title":"Clinical management of snakebite envenoming: future perspectives","volume":"11","author":"Hamza","year":"2021","journal-title":"Toxicon X"},{"key":"10.1016\/j.toxicon.2023.107225_bib9","doi-asserted-by":"crossref","first-page":"e569","DOI":"10.1371\/journal.pntd.0000569","article-title":"Snake envenoming: a disease of poverty","volume":"3","author":"Harrison","year":"2009","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.toxicon.2023.107225_bib10","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1016\/j.vaccine.2005.01.013","article-title":"Human-derived, plant-produced monoclonal antibody for the treatment of anthrax","volume":"23","author":"Hull","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.toxicon.2023.107225_bib11","doi-asserted-by":"crossref","first-page":"703","DOI":"10.3389\/fbioe.2020.00703","article-title":"Cost of manufacturing for recombinant snakebite antivenoms","volume":"8","author":"Jenkins","year":"2020","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.toxicon.2023.107225_bib12","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1111\/pbi.12823","article-title":"A synthetic biology approach for consistent production of plant-made recombinant polyclonal antibodies against snake venom toxins","volume":"16","author":"Julve Parre\u00f1o","year":"2018","journal-title":"Plant Biotechnol. J."},{"key":"10.1016\/j.toxicon.2023.107225_bib13","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.toxicon.2019.06.005","article-title":"Engineering and design considerations for next-generation snakebite antivenoms","volume":"167","author":"Knudsen","year":"2019","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2023.107225_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0017541","article-title":"Plant-made trastuzumab (herceptin) inhibits HER2\/Neu+ cell proliferation and retards tumor growth","volume":"6","author":"Komarova","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.toxicon.2023.107225_bib15","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jprot.2016.08.024","article-title":"Exploring the venom of the forest cobra snake: toxicovenomics and antivenom profiling of Naja melanoleuca","volume":"150","author":"Lauridsen","year":"2017","journal-title":"J. Proteonomics"},{"key":"10.1016\/j.toxicon.2023.107225_bib16","series-title":"Handbook of Venoms and Toxins of Reptiles","first-page":"499","article-title":"Antivenom in the age of recombinant DNA technology","author":"Laustsen","year":"2021"},{"key":"10.1016\/j.toxicon.2023.107225_bib17","doi-asserted-by":"crossref","first-page":"309","DOI":"10.3390\/toxins10080309","article-title":"Integrating engineering, manufacturing, and regulatory considerations in the development of novel antivenoms","volume":"10","author":"Laustsen","year":"2018","journal-title":"Toxins"},{"key":"10.1016\/j.toxicon.2023.107225_bib18","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.toxicon.2015.03.001","article-title":"Snake venomics of monocled cobra (Naja kaouthia) and investigation of human IgG response against venom toxins","volume":"99","author":"Laustsen","year":"2015","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2023.107225_bib19","doi-asserted-by":"crossref","first-page":"5270","DOI":"10.2174\/1381612822666160623073438","article-title":"From fangs to pharmacology: the future of snakebite envenoming therapy","volume":"22","author":"Laustsen","year":"2016","journal-title":"Curr. Pharmaceut. Des."},{"key":"10.1016\/j.toxicon.2023.107225_bib20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005361","article-title":"Recombinant snakebite antivenoms: a cost-competitive solution to a neglected tropical disease?","volume":"11","author":"Laustsen","year":"2017","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.toxicon.2023.107225_bib21","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.toxicon.2018.03.004","article-title":"Pros and cons of different therapeutic antibody formats for recombinant antivenom development","volume":"146","author":"Laustsen","year":"2018","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2023.107225_bib22","doi-asserted-by":"crossref","first-page":"3928","DOI":"10.1038\/s41467-018-06086-4","article-title":"In vivo neutralization of dendrotoxin-mediated neurotoxicity of black mamba venom by oligoclonal human IgG antibodies","volume":"9","author":"Laustsen","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.toxicon.2023.107225_bib23","doi-asserted-by":"crossref","DOI":"10.1080\/19420862.2022.2085536","article-title":"In vitro discovery of a human monoclonal antibody that neutralizes lethality of cobra snake venom","volume":"14","author":"Ledsgaard","year":"2022","journal-title":"mAbs"},{"key":"10.1016\/j.toxicon.2023.107225_bib24","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/s41467-023-36393-4","article-title":"Discovery and optimization of a broadly-neutralizing human monoclonal antibody against long-chain \u03b1-neurotoxins from snakes","volume":"14","author":"Ledsgaard","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.toxicon.2023.107225_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.toxicon.2022.106991","article-title":"Neutralization capacity of recombinant antivenoms based on monoclonal antibodies and nanobodies","volume":"222","author":"Ljungars","year":"2023","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2023.107225_bib26","doi-asserted-by":"crossref","DOI":"10.1002\/pro.4296","article-title":"Synthetic antibodies block receptor binding and current-inhibiting effects of \u03b1-cobratoxin from Naja kaouthia","volume":"31","author":"Miersch","year":"2022","journal-title":"Protein Sci."},{"key":"10.1016\/j.toxicon.2023.107225_bib27","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s12977-021-00560-6","article-title":"Characterisation of a highly potent and near pan-neutralising anti-HIV monoclonal antibody expressed in tobacco plants","volume":"18","author":"Moore","year":"2021","journal-title":"Retrovirology"},{"key":"10.1016\/j.toxicon.2023.107225_bib28","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.copbio.2019.10.005","article-title":"Molecular Pharming for low and middle income countries","volume":"61","author":"Murad","year":"2020","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.toxicon.2023.107225_bib29","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1002\/bit.28073","article-title":"Multiple gene expression in plants using MIDAS-P, a versatile type II restriction-based modular expression vector","volume":"119","author":"Pinneh","year":"2022","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.toxicon.2023.107225_bib30","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.3389\/fimmu.2019.01598","article-title":"History of envenoming therapy and current perspectives","volume":"10","author":"Pucca","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.toxicon.2023.107225_bib31","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1126\/science.1075173","article-title":"Medicine. The intangible value of vaccination","volume":"297","author":"Rappuoli","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.toxicon.2023.107225_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0069495","article-title":"In vivo neutralization of \u03b1-cobratoxin with high-affinity llama single-domain antibodies (VHHs) and a VHH-Fc antibody","volume":"8","author":"Richard","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.toxicon.2023.107225_bib33","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.ijbiomac.2020.02.028","article-title":"Generation and In-planta expression of a recombinant single chain antibody with broad neutralization activity on Bothrops pauloensis snake venom","volume":"149","author":"Souza","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.toxicon.2023.107225_bib34","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/pbi.13207","article-title":"Engineering the interactions between a plant-produced HIV antibody and human Fc receptors","volume":"18","author":"Stelter","year":"2020","journal-title":"Plant Biotechnol. J."},{"key":"10.1016\/j.toxicon.2023.107225_bib35","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/pbi.12137","article-title":"Characterization of VRC01, a potent and broadly neutralizing anti-HIV mAb, produced in transiently and stably transformed tobacco","volume":"12","author":"Teh","year":"2014","journal-title":"Plant Biotechnol. J."},{"key":"10.1016\/j.toxicon.2023.107225_bib36","first-page":"2","article-title":"Snake-bite envenoming: a priority neglected tropical disease","volume":"390","author":"The Lancet","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.toxicon.2023.107225_bib37","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1093\/infdis\/jiu085","article-title":"Engineering, expression in transgenic plants and characterisation of E559, a rabies virus-neutralising monoclonal antibody","volume":"210","author":"van Dolleweerd","year":"2014","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.toxicon.2023.107225_bib38","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1038\/s41587-022-01582-x","article-title":"Biopharmaceutical benchmarks 2022","volume":"40","author":"Walsh","year":"2022","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.toxicon.2023.107225_bib39","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1111\/pbi.12932","article-title":"A polymeric immunoglobulin-antigen fusion protein strategy for enhancing vaccine immunogenicity","volume":"16","author":"Webster","year":"2018","journal-title":"Plant Biotechnol. J."},{"key":"10.1016\/j.toxicon.2023.107225_bib40","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0007059","article-title":"Strategy for a globally coordinated response to a priority neglected tropical disease: snakebite envenoming","volume":"13","author":"Williams","year":"2019","journal-title":"PLoS Neglected Trop. Dis."}],"container-title":["Toxicon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041010123002118?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041010123002118?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T21:25:46Z","timestamp":1758576346000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041010123002118"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":40,"alternative-id":["S0041010123002118"],"URL":"https:\/\/doi.org\/10.1016\/j.toxicon.2023.107225","relation":{},"ISSN":["0041-0101"],"issn-type":[{"value":"0041-0101","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characterisation of two snake toxin-targeting human monoclonal immunoglobulin G antibodies expressed in tobacco plants","name":"articletitle","label":"Article Title"},{"value":"Toxicon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.toxicon.2023.107225","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"107225"}}